These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6767311)

  • 1. [Surgical method and combination chemotherapy in treating stage-III and IV ovarian cancer].
    Grigorova TM; Vartanian LG; Marenich AF
    Vopr Onkol; 1980; 26(2):81-5. PubMed ID: 6767311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
    Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
    Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of 2 combined treatment regimens in stage-III to -IV ovarian cancer].
    Evdokimova NI; Grigorova TM
    Vopr Onkol; 1982; 28(7):28-34. PubMed ID: 7101824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
    Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
    Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endolymphatic chemotherapy of cervix neoplasms].
    Il'inskaia EG; Pankov AK; Sidorenko IuS; Birbraer VM; Bordiushkov IuN
    Vopr Onkol; 1976; 22(10):38-44. PubMed ID: 827853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
    Greco FA; Julian CG; Richardson RL; Burnett L; Hande KR; Oldham RK
    Obstet Gynecol; 1981 Aug; 58(2):199-205. PubMed ID: 6789265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemosorption and polychemotherapy with hyperglycemia in the treatment of ovarian cancer].
    Lisetskiĭ VA; Evtushenko GV; Dotsenko IuS; Svintsitskiĭ VS
    Vrach Delo; 1990 Apr; (4):87-9. PubMed ID: 2125767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative polychemotherapy in the overall treatment of locally spread breast cancer (immediate results)].
    Sokolova IG; Vishniakova EG; Sviatukhina OV
    Vopr Onkol; 1980; 26(5):9-13. PubMed ID: 7385720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic grade in advanced ovarian cancer.
    Ozols RF; Garvin AJ; Costa J; Simon RM; Young RC
    Cancer Treat Rep; 1979 Feb; 63(2):255-63. PubMed ID: 109199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
    Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
    Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of advanced breast cancer--actual results ].
    Matthes ML; Lenk H; Gürtler R; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 20. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.